Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2], Anmol Pitliya, M.B.B.S. M.D.[3]
Overview
Classification
| | Defects in Intrinsic & Innate Immunity | | |
| | | | | | | | | | |
| | | | | |
(A) Bacterial and Parasitic Infections | | (A) Bacterial and Parasitic Infections |
Bacterial and Parasitic infections
| | | | | | | | | | | | | | | | | Defects in Intrinsic & Innate Immunity: (A) Bacterial and Parasitic Infections | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Predisposition to Invasive Bacterial Infections (pyrogens) | | | | | | | | | | | | Predisposition to Parasitic & Fungal Infections | | | | | | | | | | | | Others | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | |
| | | | | | IRAK4 Deficiency, IRAK4, AR, MyD88 Deficiency, MYD88, AR | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Osteopetrosis | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | IRAK-1 Deficiency:IRAK1,XL | | | | | | | | | | Predisposition to mucocutaneous candidiasis(CMC) | | | | | CARD9 Deficiency, CARD9, AR | | | | | | | | | | Hyderadenitis Suppurativa | | |
| | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | TIRAP Deficiency, TIRAP, AR | | | | | | | | | | STAT1 GOF, STAT1, AD | | | | | Trypanosomiasis APOL1, AD | | | | | | | | | | Acute liver failure due to NBAS deficiency, NBAS, AR | | |
| | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | Isolated Congenital Asplenia, RPSA, AD; HMOX, AR | | | | | | | | | | IL-17F Deficiency, IL-17F, AD | | | | | | | | | | | | | | | | Acute necrotizing encephalopathy, RANBP2, AD | | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | IL-17RA Deficiency, IL-17RA, AR | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | IL-17RC Deficiency, IL-17RC, AR | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | ACT1 Deficiency, ACT1, AR | | | | | | | | | | | | | | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
MSMD and Viral Infections
| | | | | | | | | | | | | | | | Defects in Intrinsic & Innate Immunity: (B) MSMD & Viral Infections | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | Mendelian susceptibility to mycobacterial disease(MSMD) | | | | | | | | | | | | | | | | | | | | | | Predominant susceptibility to viral infections | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| Severe Phenotypes | | | | Moderate Phenotypes | | | | | | | | | | | Epidermodysplasia verruciformis(HPV) | | | | | | Predisposition to severe viral infections | | | | | Herpes simplex encephalitis | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Complete IFNGR1 def: and IFNGR2 def:, IFNGR1,IFNGR2,AR | | | | | | | IL12 & 23 receptor B1 chain def:, IL12P40 def:, STAT1 LOF, Partial IFNYR1 & 2, AD IFNGR1, TyK2 def: | | | | | | | | | | | | EVER1 def:, TMC6, AR | | | | | | | STAT1 def: (AR LOF) | | | | | | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | ISG15 def:, ISG15,AR; Macrophage Gp91 Phox def:CYBB,XL,IRG8 def:,IRF8,AD; IRF8 def:, IRF8 AR; RORc def:, ROCR,AR; JACK1(LOF),JAK1,AR | | | | | | | | | | | | EVER2 def:, TMC8,AR | | | | | | | STAT2 def: (STAT2 AR) | | | | | | |
| | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | WHIM (Warts, Hypogammaglobulinemia, Infections, Myelokathexis) Syndrome, CXCR4, AD,GOF | | | | | | | IRF7 def: (IRF7,AR) | | | | | | |
| |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | {{{ G01 }}} | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | CD16 def: (FCGR3A,AR) | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | MDAS def: (LOF), IFIH1,AR | | | | | | |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
References